Skip to Content
Merck
CN
  • Use of phosphodiesterase type 3 inhibitor to improve IVM outcome: experimental set up matters.

Use of phosphodiesterase type 3 inhibitor to improve IVM outcome: experimental set up matters.

Fertility and sterility (2009-04-04)
Daniela Nogueira, Leen Vanhoutte
PMID19342017
MATERIALS
Product Number
Brand
Product Description
C7971
Sigma-Aldrich
Cilostamide, phosphodiesterase inhibitor